4/18
10:01 am
nrxp
Veru, EyePoint Pharmaceuticals, Sintx Technologies among healthcare movers [Seeking Alpha]
Low
Report
Veru, EyePoint Pharmaceuticals, Sintx Technologies among healthcare movers [Seeking Alpha]
4/18
08:32 am
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement
Medium
Report
NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement
4/18
08:30 am
nrxp
NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock
Medium
Report
NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock
4/17
04:51 pm
nrxp
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock [Yahoo! Finance]
High
Report
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock [Yahoo! Finance]
4/17
04:45 pm
nrxp
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
High
Report
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
4/17
08:50 am
nrxp
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections [Yah
Low
Report
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections [Yah
4/17
08:30 am
nrxp
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections
Low
Report
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections
4/15
08:39 am
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine) [Yahoo! Finance]
Medium
Report
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine) [Yahoo! Finance]
4/15
08:30 am
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)
Medium
Report
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)
4/8
08:34 am
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression [Yahoo! Finance]
Low
Report
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression [Yahoo! Finance]
4/8
08:30 am
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
Medium
Report
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
4/4
01:37 pm
nrxp
NRx Pharmaceuticals (NRXP) Upgraded to Strong Buy: Here's What You Should Know [Yahoo! Finance]
Medium
Report
NRx Pharmaceuticals (NRXP) Upgraded to Strong Buy: Here's What You Should Know [Yahoo! Finance]
4/1
08:48 am
nrxp
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
4/1
08:28 am
nrxp
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Medium
Report
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
3/28
08:17 am
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights [Yahoo! Finance]
Medium
Report
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights [Yahoo! Finance]
3/28
08:09 am
nrxp
NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing [Yahoo! Finance]
Medium
Report
NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing [Yahoo! Finance]
3/28
08:03 am
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights
Medium
Report
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights
3/28
08:00 am
nrxp
NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
Medium
Report
NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
3/26
04:18 pm
nrxp
UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 [Yahoo! Finance]
Low
Report
UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 [Yahoo! Finance]
3/26
04:03 pm
nrxp
UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
Low
Report
UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
3/25
08:44 am
nrxp
NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK [Yahoo! Finance]
Neutral
Report
NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK [Yahoo! Finance]
3/25
08:30 am
nrxp
NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK
Low
Report
NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK
3/21
04:14 pm
nrxp
NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024 [Yahoo! Finance]
High
Report
NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024 [Yahoo! Finance]
3/21
04:02 pm
nrxp
NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024
High
Report
NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024
3/21
02:12 pm
nrxp
NRx Pharmaceuticals Announces Results of the Vote Held During the Special Meeting of Shareholders [Yahoo! Finance]
Low
Report
NRx Pharmaceuticals Announces Results of the Vote Held During the Special Meeting of Shareholders [Yahoo! Finance]